Hyperpigmented Patch on the Leg

Article Type
Changed
Thu, 01/10/2019 - 13:45
Display Headline
Hyperpigmented Patch on the Leg

The Diagnosis: Lichen Aureus

The clinicopathological findings were diagnostic of lichen aureus (LA). Microscopic examination revealed a relatively sparse, superficial, perivascular and interstitial lymphohistiocytic infiltrate with scattered siderophages in the upper dermis. Extravasation of red blood cells also was noted (Figure 1). An immunohistochemical stain for Melan-A highlighted a normal number and distribution of single melanocytes at the dermoepidermal junction with no evidence of pagetoid scatter. A Perls Prussian blue stain for iron demonstrated abundant hemosiderin in the dermis (Figure 2).

Figure 1. Lichen aureus histopathology revealed a superficial lymphohistiocytic infiltrate (A)(H&E, original magnification ×40) with scattered siderophages and extravasated red blood cells (B)(H&E, original magnification ×200).

Figure 2. Lichen aureus histopathology using the Perls Prussian blue stain for iron demonstrated abundant hemosiderin in the dermis (original magnification ×40).

Pigmented purpuric dermatosis (PPD) describes a group of cutaneous lesions that are characterized by petechiae and pigmentary changes. These lesions most commonly present on the lower limbs; however, other sites have been reported.1 This group includes several major clinical forms such as Schamberg disease, LA, purpura annularis telangiectodes of Majocchi, eczematidlike purpura of Doucas and Kapetanakis, and lichenoid PPD of Gougerot and Blum. Lesions typically demonstrate a striking golden brown color clinically and by definition occur in the absence of platelet defects or vasculitis.1

Factors implicated in the pathogenesis of pigmented purpura include gravitational dependency, venous stasis, infection, and drugs.2 It is suggested that cellular immunity may play a role in the development of the disease based on the presence of CD4+ T lymphocytes in the infiltrate and the expression of HLA-DR by these lymphocytes and the keratinocytes.3 Lichen aureus differs in that it relates to increased intravascular pressure from an incompetent valve in an underlying perforating vein.4

Lichen aureus, also referred to as lichen purpuricus, is one major variant of PPD. The name reflects both the characteristic golden brown color and the histopathologic pattern of inflammation.1 Lichen aureus usually presents as a unilateral, asymptomatic, confined single lesion located mainly on the leg,1 though it can develop at other sites or as a localized group of lesions. Extensive lesions have been reported5 and cases with a segmental distribution have been described.6 In contrast, Schamberg disease demonstrates pinhead-sized reddish lesions giving the characteristic cayenne pepper pigmentation. These lesions coalesce to form thumbprint patches that progress proximally.1 Majocchi purpura is annular and telangiectatic, while lichenoid purpura of Gougerot and Blum presents with flat-topped, polygonal, violaceous papules that turn brown over time.

Some authors have championed a role for dermoscopy in diagnosis of LA.7 By dermoscopy, LA demonstrates a diffuse copper background reflecting the lymphohistiocytic dermal infiltrate, red dots and globules representing the extravasated red blood cells and the dilated swollen vessels, and grey dots that reflect the hemosiderin present in the dermis.8

Histologically, LA demonstrates a superficial perivascular infiltrate composed mainly of CD4+ lymphocytes surrounding the superficial capillaries. Over time, red cell extravasation leads to the formation of hemosiderin-laden macrophages, which can be highlighted with Perls Prussian blue stain. A bandlike infiltrate with thin strands of collagen separating it from the epidermis also may be noted.9

An important consideration in the differential diagnosis of PPD is mycosis fungoides (MF). Mycosis fungoides is a cutaneous T-cell lymphoma that clinically presents as a single or multiple hypopigmented or hyperpigmented patches or as erythematous scaly lesions in the patch or plaque stage. These lesions eventually may evolve into tumor stage.10 Mycosis fungoides may mimic PPD clinically and/or histopathologically, and rarely PPD also may precede MF.11 Involvement of the trunk, especially the lower abdomen and buttock region, favors a diagnosis of MF. Typically, histopathologic examination of MF demonstrates an epidermotropic lymphocytic infiltrate composed of atypical cerebriform lymphocytes overlying papillary dermal fibrosis. Although classic MF would be difficult to confuse with PPD, the atrophic lichenoid pattern of MF may show remarkable overlap with PPD.12 Such cases require clinicopathologic correlation, immunophenotyping of the epidermotropic lymphocytes, and occasionally T-cell clonality studies.

Lichen aureus is a chronic persistent disease unless the underlying incompetent perforator vessel is ligated. Various treatments have been used for other forms of pigmented purpura including topical corticosteroids, topical tacrolimus, systemic vasodilators such as prostacyclin and pentoxifylline, and phototherapy.1 Clinical follow-up is recommended for lesions that show some clinical or histopathological overlap with MF. Additional biopsies also may prove useful in establishing a definitive diagnosis in ambiguous cases.

References
  1. Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482-488.
  2. Newton RC, Raimer SS. Pigmented purpuric eruptions. Dermatol Clin. 1985;3:165-169.
  3. Aiba S, Tagami H. Immunohistologic studies in Schamberg's disease. evidence for cellular immune reaction in lesional skin. Arch Dermatol. 1988;124:1058-1062.
  4. English J. Lichen aureus. J Am Acad Dermatol. 1985;12(2, pt 1):377-379.
  5. Duhra P, Tan CY. Lichen aureus. Br J Dermatol. 1986;114:395.
  6. Moche J, Glassman S, Modi D, et al. Segmental lichen aureus: a report of two cases treated with methylprednisolone aceponate. Australas J Dermatol. 2011;52:E15-E18.  
  7. Zaballos P, Puig S, Malvehy J. Dermoscopy of pigmented purpuric dermatoses (lichen aureus): a useful tool for clinical diagnosis. Arch Dermatol. 2004;140:1290-1291.  
  8. Portela PS, Melo DF, Ormiga P, et al. Dermoscopy of lichen aureus. An Bras Dermatol. 2013;88:253-255.
  9. Smoller BR, Kamel OW. Pigmented purpuric eruptions: immunopathologic studies supportive of a common immunophenotype. J Cutan Pathol. 1991;18:423-427.
  10. Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. a progress report. Am J Clin Pathol. 1999;111(1 suppl 1):S8-S12.
  11. Hanna S, Walsh N, D'Intino Y, et al. Mycosis fungoides presenting as pigmented purpuric dermatitis. Pediatr Dermatol. 2006;23:350-354.
  12. Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? a study by light microscopy and molecular methods. Am J Dermatopathol. 1997;19:108-118.
Article PDF
Author and Disclosure Information

Drs. Elbendary and Elston were from and Dr. Heller is from Ackerman Academy of Dermatopathology, New York, New York. Dr. Elbendary currently is from the Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Egypt. Dr. Elston currently is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston. Dr. Dunlop is from Aurora Diagnostics, Twin Cities Dermatopathology, Plymouth, Minnesota. Dr. Goulko is from Dermatology & Laser Surgery Center, Fort Lee, New Jersey.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, 11th Floor, Charleston, SC 29425 ([email protected]).

Issue
Cutis - 100(3)
Publications
Topics
Page Number
E1-E3
Sections
Author and Disclosure Information

Drs. Elbendary and Elston were from and Dr. Heller is from Ackerman Academy of Dermatopathology, New York, New York. Dr. Elbendary currently is from the Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Egypt. Dr. Elston currently is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston. Dr. Dunlop is from Aurora Diagnostics, Twin Cities Dermatopathology, Plymouth, Minnesota. Dr. Goulko is from Dermatology & Laser Surgery Center, Fort Lee, New Jersey.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, 11th Floor, Charleston, SC 29425 ([email protected]).

Author and Disclosure Information

Drs. Elbendary and Elston were from and Dr. Heller is from Ackerman Academy of Dermatopathology, New York, New York. Dr. Elbendary currently is from the Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Egypt. Dr. Elston currently is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston. Dr. Dunlop is from Aurora Diagnostics, Twin Cities Dermatopathology, Plymouth, Minnesota. Dr. Goulko is from Dermatology & Laser Surgery Center, Fort Lee, New Jersey.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, 11th Floor, Charleston, SC 29425 ([email protected]).

Article PDF
Article PDF
Related Articles

The Diagnosis: Lichen Aureus

The clinicopathological findings were diagnostic of lichen aureus (LA). Microscopic examination revealed a relatively sparse, superficial, perivascular and interstitial lymphohistiocytic infiltrate with scattered siderophages in the upper dermis. Extravasation of red blood cells also was noted (Figure 1). An immunohistochemical stain for Melan-A highlighted a normal number and distribution of single melanocytes at the dermoepidermal junction with no evidence of pagetoid scatter. A Perls Prussian blue stain for iron demonstrated abundant hemosiderin in the dermis (Figure 2).

Figure 1. Lichen aureus histopathology revealed a superficial lymphohistiocytic infiltrate (A)(H&E, original magnification ×40) with scattered siderophages and extravasated red blood cells (B)(H&E, original magnification ×200).

Figure 2. Lichen aureus histopathology using the Perls Prussian blue stain for iron demonstrated abundant hemosiderin in the dermis (original magnification ×40).

Pigmented purpuric dermatosis (PPD) describes a group of cutaneous lesions that are characterized by petechiae and pigmentary changes. These lesions most commonly present on the lower limbs; however, other sites have been reported.1 This group includes several major clinical forms such as Schamberg disease, LA, purpura annularis telangiectodes of Majocchi, eczematidlike purpura of Doucas and Kapetanakis, and lichenoid PPD of Gougerot and Blum. Lesions typically demonstrate a striking golden brown color clinically and by definition occur in the absence of platelet defects or vasculitis.1

Factors implicated in the pathogenesis of pigmented purpura include gravitational dependency, venous stasis, infection, and drugs.2 It is suggested that cellular immunity may play a role in the development of the disease based on the presence of CD4+ T lymphocytes in the infiltrate and the expression of HLA-DR by these lymphocytes and the keratinocytes.3 Lichen aureus differs in that it relates to increased intravascular pressure from an incompetent valve in an underlying perforating vein.4

Lichen aureus, also referred to as lichen purpuricus, is one major variant of PPD. The name reflects both the characteristic golden brown color and the histopathologic pattern of inflammation.1 Lichen aureus usually presents as a unilateral, asymptomatic, confined single lesion located mainly on the leg,1 though it can develop at other sites or as a localized group of lesions. Extensive lesions have been reported5 and cases with a segmental distribution have been described.6 In contrast, Schamberg disease demonstrates pinhead-sized reddish lesions giving the characteristic cayenne pepper pigmentation. These lesions coalesce to form thumbprint patches that progress proximally.1 Majocchi purpura is annular and telangiectatic, while lichenoid purpura of Gougerot and Blum presents with flat-topped, polygonal, violaceous papules that turn brown over time.

Some authors have championed a role for dermoscopy in diagnosis of LA.7 By dermoscopy, LA demonstrates a diffuse copper background reflecting the lymphohistiocytic dermal infiltrate, red dots and globules representing the extravasated red blood cells and the dilated swollen vessels, and grey dots that reflect the hemosiderin present in the dermis.8

Histologically, LA demonstrates a superficial perivascular infiltrate composed mainly of CD4+ lymphocytes surrounding the superficial capillaries. Over time, red cell extravasation leads to the formation of hemosiderin-laden macrophages, which can be highlighted with Perls Prussian blue stain. A bandlike infiltrate with thin strands of collagen separating it from the epidermis also may be noted.9

An important consideration in the differential diagnosis of PPD is mycosis fungoides (MF). Mycosis fungoides is a cutaneous T-cell lymphoma that clinically presents as a single or multiple hypopigmented or hyperpigmented patches or as erythematous scaly lesions in the patch or plaque stage. These lesions eventually may evolve into tumor stage.10 Mycosis fungoides may mimic PPD clinically and/or histopathologically, and rarely PPD also may precede MF.11 Involvement of the trunk, especially the lower abdomen and buttock region, favors a diagnosis of MF. Typically, histopathologic examination of MF demonstrates an epidermotropic lymphocytic infiltrate composed of atypical cerebriform lymphocytes overlying papillary dermal fibrosis. Although classic MF would be difficult to confuse with PPD, the atrophic lichenoid pattern of MF may show remarkable overlap with PPD.12 Such cases require clinicopathologic correlation, immunophenotyping of the epidermotropic lymphocytes, and occasionally T-cell clonality studies.

Lichen aureus is a chronic persistent disease unless the underlying incompetent perforator vessel is ligated. Various treatments have been used for other forms of pigmented purpura including topical corticosteroids, topical tacrolimus, systemic vasodilators such as prostacyclin and pentoxifylline, and phototherapy.1 Clinical follow-up is recommended for lesions that show some clinical or histopathological overlap with MF. Additional biopsies also may prove useful in establishing a definitive diagnosis in ambiguous cases.

The Diagnosis: Lichen Aureus

The clinicopathological findings were diagnostic of lichen aureus (LA). Microscopic examination revealed a relatively sparse, superficial, perivascular and interstitial lymphohistiocytic infiltrate with scattered siderophages in the upper dermis. Extravasation of red blood cells also was noted (Figure 1). An immunohistochemical stain for Melan-A highlighted a normal number and distribution of single melanocytes at the dermoepidermal junction with no evidence of pagetoid scatter. A Perls Prussian blue stain for iron demonstrated abundant hemosiderin in the dermis (Figure 2).

Figure 1. Lichen aureus histopathology revealed a superficial lymphohistiocytic infiltrate (A)(H&E, original magnification ×40) with scattered siderophages and extravasated red blood cells (B)(H&E, original magnification ×200).

Figure 2. Lichen aureus histopathology using the Perls Prussian blue stain for iron demonstrated abundant hemosiderin in the dermis (original magnification ×40).

Pigmented purpuric dermatosis (PPD) describes a group of cutaneous lesions that are characterized by petechiae and pigmentary changes. These lesions most commonly present on the lower limbs; however, other sites have been reported.1 This group includes several major clinical forms such as Schamberg disease, LA, purpura annularis telangiectodes of Majocchi, eczematidlike purpura of Doucas and Kapetanakis, and lichenoid PPD of Gougerot and Blum. Lesions typically demonstrate a striking golden brown color clinically and by definition occur in the absence of platelet defects or vasculitis.1

Factors implicated in the pathogenesis of pigmented purpura include gravitational dependency, venous stasis, infection, and drugs.2 It is suggested that cellular immunity may play a role in the development of the disease based on the presence of CD4+ T lymphocytes in the infiltrate and the expression of HLA-DR by these lymphocytes and the keratinocytes.3 Lichen aureus differs in that it relates to increased intravascular pressure from an incompetent valve in an underlying perforating vein.4

Lichen aureus, also referred to as lichen purpuricus, is one major variant of PPD. The name reflects both the characteristic golden brown color and the histopathologic pattern of inflammation.1 Lichen aureus usually presents as a unilateral, asymptomatic, confined single lesion located mainly on the leg,1 though it can develop at other sites or as a localized group of lesions. Extensive lesions have been reported5 and cases with a segmental distribution have been described.6 In contrast, Schamberg disease demonstrates pinhead-sized reddish lesions giving the characteristic cayenne pepper pigmentation. These lesions coalesce to form thumbprint patches that progress proximally.1 Majocchi purpura is annular and telangiectatic, while lichenoid purpura of Gougerot and Blum presents with flat-topped, polygonal, violaceous papules that turn brown over time.

Some authors have championed a role for dermoscopy in diagnosis of LA.7 By dermoscopy, LA demonstrates a diffuse copper background reflecting the lymphohistiocytic dermal infiltrate, red dots and globules representing the extravasated red blood cells and the dilated swollen vessels, and grey dots that reflect the hemosiderin present in the dermis.8

Histologically, LA demonstrates a superficial perivascular infiltrate composed mainly of CD4+ lymphocytes surrounding the superficial capillaries. Over time, red cell extravasation leads to the formation of hemosiderin-laden macrophages, which can be highlighted with Perls Prussian blue stain. A bandlike infiltrate with thin strands of collagen separating it from the epidermis also may be noted.9

An important consideration in the differential diagnosis of PPD is mycosis fungoides (MF). Mycosis fungoides is a cutaneous T-cell lymphoma that clinically presents as a single or multiple hypopigmented or hyperpigmented patches or as erythematous scaly lesions in the patch or plaque stage. These lesions eventually may evolve into tumor stage.10 Mycosis fungoides may mimic PPD clinically and/or histopathologically, and rarely PPD also may precede MF.11 Involvement of the trunk, especially the lower abdomen and buttock region, favors a diagnosis of MF. Typically, histopathologic examination of MF demonstrates an epidermotropic lymphocytic infiltrate composed of atypical cerebriform lymphocytes overlying papillary dermal fibrosis. Although classic MF would be difficult to confuse with PPD, the atrophic lichenoid pattern of MF may show remarkable overlap with PPD.12 Such cases require clinicopathologic correlation, immunophenotyping of the epidermotropic lymphocytes, and occasionally T-cell clonality studies.

Lichen aureus is a chronic persistent disease unless the underlying incompetent perforator vessel is ligated. Various treatments have been used for other forms of pigmented purpura including topical corticosteroids, topical tacrolimus, systemic vasodilators such as prostacyclin and pentoxifylline, and phototherapy.1 Clinical follow-up is recommended for lesions that show some clinical or histopathological overlap with MF. Additional biopsies also may prove useful in establishing a definitive diagnosis in ambiguous cases.

References
  1. Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482-488.
  2. Newton RC, Raimer SS. Pigmented purpuric eruptions. Dermatol Clin. 1985;3:165-169.
  3. Aiba S, Tagami H. Immunohistologic studies in Schamberg's disease. evidence for cellular immune reaction in lesional skin. Arch Dermatol. 1988;124:1058-1062.
  4. English J. Lichen aureus. J Am Acad Dermatol. 1985;12(2, pt 1):377-379.
  5. Duhra P, Tan CY. Lichen aureus. Br J Dermatol. 1986;114:395.
  6. Moche J, Glassman S, Modi D, et al. Segmental lichen aureus: a report of two cases treated with methylprednisolone aceponate. Australas J Dermatol. 2011;52:E15-E18.  
  7. Zaballos P, Puig S, Malvehy J. Dermoscopy of pigmented purpuric dermatoses (lichen aureus): a useful tool for clinical diagnosis. Arch Dermatol. 2004;140:1290-1291.  
  8. Portela PS, Melo DF, Ormiga P, et al. Dermoscopy of lichen aureus. An Bras Dermatol. 2013;88:253-255.
  9. Smoller BR, Kamel OW. Pigmented purpuric eruptions: immunopathologic studies supportive of a common immunophenotype. J Cutan Pathol. 1991;18:423-427.
  10. Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. a progress report. Am J Clin Pathol. 1999;111(1 suppl 1):S8-S12.
  11. Hanna S, Walsh N, D'Intino Y, et al. Mycosis fungoides presenting as pigmented purpuric dermatitis. Pediatr Dermatol. 2006;23:350-354.
  12. Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? a study by light microscopy and molecular methods. Am J Dermatopathol. 1997;19:108-118.
References
  1. Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482-488.
  2. Newton RC, Raimer SS. Pigmented purpuric eruptions. Dermatol Clin. 1985;3:165-169.
  3. Aiba S, Tagami H. Immunohistologic studies in Schamberg's disease. evidence for cellular immune reaction in lesional skin. Arch Dermatol. 1988;124:1058-1062.
  4. English J. Lichen aureus. J Am Acad Dermatol. 1985;12(2, pt 1):377-379.
  5. Duhra P, Tan CY. Lichen aureus. Br J Dermatol. 1986;114:395.
  6. Moche J, Glassman S, Modi D, et al. Segmental lichen aureus: a report of two cases treated with methylprednisolone aceponate. Australas J Dermatol. 2011;52:E15-E18.  
  7. Zaballos P, Puig S, Malvehy J. Dermoscopy of pigmented purpuric dermatoses (lichen aureus): a useful tool for clinical diagnosis. Arch Dermatol. 2004;140:1290-1291.  
  8. Portela PS, Melo DF, Ormiga P, et al. Dermoscopy of lichen aureus. An Bras Dermatol. 2013;88:253-255.
  9. Smoller BR, Kamel OW. Pigmented purpuric eruptions: immunopathologic studies supportive of a common immunophenotype. J Cutan Pathol. 1991;18:423-427.
  10. Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. a progress report. Am J Clin Pathol. 1999;111(1 suppl 1):S8-S12.
  11. Hanna S, Walsh N, D'Intino Y, et al. Mycosis fungoides presenting as pigmented purpuric dermatitis. Pediatr Dermatol. 2006;23:350-354.
  12. Toro JR, Sander CA, LeBoit PE. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? a study by light microscopy and molecular methods. Am J Dermatopathol. 1997;19:108-118.
Issue
Cutis - 100(3)
Issue
Cutis - 100(3)
Page Number
E1-E3
Page Number
E1-E3
Publications
Publications
Topics
Article Type
Display Headline
Hyperpigmented Patch on the Leg
Display Headline
Hyperpigmented Patch on the Leg
Sections
Questionnaire Body

A 32-year-old man presented with an asymptomatic pigmented lesion on the left foot that developed over the course of 4 months. Physical examination revealed a 4-cm asymmetrical, deeply pigmented macule on the left foot. A shave biopsy of the lesion was performed.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
PubMed ID
29121133
Disqus Comments
Default
Article PDF Media